Latest Articles

Publication Date
PRM Opens Florida's First Center of Excellence for Endometriosis and Pelvic Pain - The Manila Times

PRM Opens Florida's First Center of Excellence for Endometriosis and Pelvic Pain The Manila Times

Published: Oct. 22, 2025, 1:50 p.m.
PRM Opens Florida's First Center of Excellence for Endometriosis and Pelvic Pain - Yahoo

PRM Opens Florida's First Center of Excellence for Endometriosis and Pelvic Pain Yahoo

Published: Oct. 22, 2025, 1:44 p.m.
Cyclana Bio - The Pharma Letter

Cyclana Bio The Pharma Letter

Published: Oct. 22, 2025, 8:51 a.m.
How hormonal imbalances in metabolic syndrome fuel women’s cancer risk - The South First

How hormonal imbalances in metabolic syndrome fuel women’s cancer risk The South First

Published: Oct. 22, 2025, 1:30 a.m.
Honokiol inhibits cell migration and invasion by blocking EMT via Snail/Slug axis in endometriosis.

Endometriosis, a common gynecological disease, leads to dysmenorrhea and infertility. EMT process was closely related to the pathology of endometriosis. More therapies were required to be explored for endometriosis management. …

Published: Oct. 22, 2025, midnight
Early Contralateral Recurrence of Ovarian Endometriosis After Unilateral Surgery: A Case Report.

Endometriosis is a gynecological condition that primarily affects women of reproductive age and is a leading cause of infertility. Ovarian endometriomas (OMAs) are cystic forms often seen in advanced stages …

Published: Oct. 22, 2025, midnight
Kissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal - MSN

Kissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal MSN

Published: Oct. 21, 2025, 5:24 p.m.
Why NFX Invested in Cyclana Bio: A Bioplatform Building Physiologically Accurate Human Tissue Models - NFX

Why NFX Invested in Cyclana Bio: A Bioplatform Building Physiologically Accurate Human Tissue Models NFX

Published: Oct. 21, 2025, 4:16 p.m.
Endometriosis and Blood Clots: What’s Normal and What’s Not - HealthCentral

Endometriosis and Blood Clots: What’s Normal and What’s Not HealthCentral

Published: Oct. 21, 2025, 1:50 p.m.
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer - Pharmacy Times

KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer Pharmacy Times

Published: Oct. 21, 2025, 3:34 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!